Ocular Science launches two affiliates to focus on compounding and biologic sectors of ophthalmic market.
ASCRS FDA committee member Damien Goldberg, MD, urges FDA to allow access to compounded drugs from traditional compounders without a patient-specific prescription.
Compounded formulations for surgical vision correction, glaucoma management & myopia control.
Presbyopia Drops
